Shin Yokohama Kato Clinic

Shin Yokohama Kato Clinic is a specialized medical institution based in Yokohama, Japan, that focuses on advanced cancer immunotherapy and regenerative medicine. The clinic is widely recognized for its administration of autologous cancer vaccines, a personalized treatment modality that utilizes a patient's own tumor antigens to trigger a targeted immune response. Beyond vaccine therapy, the facility provides various adoptive immunotherapy services, including natural killer (NK) cell therapy and dendritic cell-based treatments. Led by Director Hiroshi Kato, the clinic integrates these biological therapies into comprehensive cancer care plans for patients with various solid malignancies. Their services are provided under the regulatory framework of Japan's Act on the Safety of Regenerative Medicine. The clinic aims to provide options for patients who have exhausted standard treatments or wish to combine immunotherapy with conventional oncology care.